Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.42 USD | -1.44% | -9.28% | -20.28% |
Financials (USD)
Sales 2024 * | 71.73M | Sales 2025 * | 60.34M | Capitalization | 267M |
---|---|---|---|---|---|
Net income 2024 * | -217M | Net income 2025 * | -260M | EV / Sales 2024 * | 1.43 x |
Net cash position 2024 * | 164M | Net cash position 2025 * | 368M | EV / Sales 2025 * | -1.67 x |
P/E ratio 2024 * |
-1.04
x | P/E ratio 2025 * |
-1.05
x | Employees | 302 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.03% |
Latest transcript on Sutro Biopharma, Inc.
1 day | -1.44% | ||
1 week | -9.28% | ||
Current month | -39.47% | ||
1 month | +4.59% | ||
3 months | -24.84% | ||
6 months | +21.28% | ||
Current year | -20.28% |
Managers | Title | Age | Since |
---|---|---|---|
William Newell
CEO | Chief Executive Officer | 66 | 09-01-13 |
Jane Chung
PSD | President | 53 | 21-08-08 |
Edward Albini
DFI | Director of Finance/CFO | 66 | 13-01-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 19-06-23 |
James Panek
BRD | Director/Board Member | 71 | 20-01-06 |
Daniel Petree
BRD | Director/Board Member | 68 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 9 M€ | +5.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 3.42 | -1.44% | 538,890 |
24-04-24 | 3.47 | -6.72% | 731,249 |
24-04-23 | 3.72 | -1.33% | 722,440 |
24-04-22 | 3.77 | +3.86% | 515,209 |
24-04-19 | 3.63 | -3.71% | 515,911 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.28% | 267M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- STRO Stock